Project Grant R01MH139659
Award Date 9/1/26
Completion Date 7/31/31
Dollars Obligated $720K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55454, USA
Similar Awards
- The National Institute of Mental Health awarded The Johns Hopkins University $807,893 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct advanced magnetic resonance imaging research on neurovascular abnormalities in individuals with schizophrenia across the life span. The recipient will perform quantitative MR imaging at 7 Tesla field strength to test the hypothesis that cerebral microvasculature and cerebrospinal fluid circulation and clearance...
- The National Institute of Mental Health awarded the Regents of the University of Minnesota $726,312 on August 16, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct preclinical research on explore-exploit balance as a cross-species index of cognitive flexibility in relation to serious mental health conditions including schizophrenia and mood disorders. The recipient will use touchscreen cognitive tasks and computational modeling to measure explore versus exploit...
- The National Institute of Mental Health awarded the Regents of the University of Minnesota $167,473 on January 2, 2026, for a project grant under the Mental Health Research Grants program (CFDA 93.242) to measure neuroplastic effects of oscillation-locked transcranial magnetic stimulation. The research addresses treatment-resistant major depressive disorder, which affects more than 30 percent of individuals with MDD who show no response to two or more antidepressant interventions. The project...
- The National Institute of Mental Health awarded $615,444 to the Regents of the University of Minnesota on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop precise functional characterization of the developing infant brain using a clinical 7T MRI scanner. The award funds research to establish reliable quantitative neuroimaging methods for infants during their first year of life, addressing a gap in current knowledge about early brain functional organization...
- The National Institute of Mental Health awarded the University of California, Los Angeles $817,686 under the Mental Health Research Grants program (CFDA 93.242) on April 25, 2026, to investigate autonomic regulation of brain function and cognition in patients with first-episode schizophrenia and healthy individuals. The project examines how dysfunction in the autonomic nervous system mechanistically contributes to disorganized brain activity and cognitive impairment in schizophrenia, focusing on...
- The National Institute of Mental Health awarded the University of Rochester $437,496 on April 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate blood-brain barrier and glymphatic clearance disruptions as biomarkers for schizophrenia spectrum disorders in mid- to late-life first episode psychosis. The research examines interactions among three barrier systems regulating trafficking between blood and brain: the blood-brain barrier, blood-cerebrospinal fluid...
- The National Institute of Mental Health awarded the Regents of the University of Minnesota $149,177 on February 27, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct research into valuation mechanisms linking phasic and tonic dopamine dynamics and their role in flexible motivational engagement. The award funds a two-aim research project that uses a novel broadband dopamine measurement technique to analyze how dopamine fluctuates across fast phasic and slower tonic...
- The National Institute of Mental Health awarded the University of Pittsburgh $739,727 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop federated statistical harmonization and multivariate modeling frameworks for investigating altered brain aging patterns in individuals with severe mental illness and the modifying effects of metabolic syndrome. The project addresses methodological challenges in large-scale neuroimaging research by leveraging the ENIGMA...
- The National Institute of Mental Health awarded the University of Texas Health Science Center at Houston $777,176 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test biomarker-supported prevention intervention for schizophrenia spectrum disorder in at-risk children. The project will recruit children aged 9 to 18 with significant family history of schizophrenia spectrum disorder and other modifiable risk factors but without subclinical or...
- The National Institute of Mental Health awarded The Johns Hopkins University $538,657 on July 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop Neural Navigator, a standardized platform for quantifying circuit pathophysiology in patient-derived cerebral organoids using multi-electrode array recordings and machine learning-based modeling to decode psychiatric disorder signatures in schizophrenia and bipolar disorder. The project aims to establish reproducible...